Have a personal or library account? Click to login
High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer Cover

High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer

Radiology and Oncology
Volume 51 (2017): Issue 3 (September 2017)
By: Takashi Ono,  Tomonori Yabuuchi,  Tatsuya Nakamura,  Kanako Kimura,  Yusuke Azami,  Katsumi Hirose,  Motohisa Suzuki,  Hitoshi Wada,  Yasuhiro Kikuchi and  Kenji Nemoto  
Open Access
|Jun 2017
DOI: https://doi.org/10.1515/raon-2017-0023 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 324 - 330
Submitted on: Jan 17, 2017
Accepted on: May 14, 2017
Published on: Jun 16, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
central,
lung cancer,
hypofractionated,
proton beam therapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2017 Takashi Ono, Tomonori Yabuuchi, Tatsuya Nakamura, Kanako Kimura, Yusuke Azami, Katsumi Hirose, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Nemoto, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 51 (2017): Issue 3 (September 2017)Next article